GENMAB AS SP.ADR/1/10DK 1 (GE91) — Long-term Investment Intensity
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Long-term Investment Intensity of 0.3% as of December 2025. Long-term investments of €37.00 Million represent 0.3% of total assets of €12.87 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GENMAB AS SP.ADR/1/10DK 1 (GE91) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GENMAB AS SP.ADR/1/10DK 1 Long-term Investment Intensity (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 0.3%, reflecting long-term investments of €37.00 Million against total assets of €12.87 Billion EUR. Explore GENMAB AS SP.ADR/1/10DK 1 (GE91) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is GENMAB AS SP.ADR/1/10DK 1 worth.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.3% | €37.00 Million | €12.87 Billion | ▼ -0.2 pp |
| 2024 | 0.5% | €31.81 Million | €6.39 Billion | ▲ +0.1 pp |
| 2023 | 0.4% | €19.90 Million | €5.24 Billion | ▼ -0.1 pp |
| 2022 | 0.4% | €19.14 Million | €4.33 Billion | ▼ -1.1 pp |
| 2021 | 1.5% | €56.48 Million | €3.75 Billion | — |